Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Clover HealthCLOV |
-$111M |
 |
MetLifeMET |
-$96M |
 |
AflacAFL |
-$242M |
 |
ProgressivePGR |
-$2.01B |
 |
CenteneCNC |
$14M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| DeVore Susan D. | Aug 19, 2025 | Buy | 1,200 | $312.15 | $370,000 |
| BOUDREAUX GAIL | Jul 18, 2025 | Buy | 5,116 | $287.12 | $1.5M |
| BOUDREAUX GAIL | Jul 18, 2025 | Buy | 2,334 | $286.07 | $670,000 |
| BOUDREAUX GAIL | Jul 18, 2025 | Buy | 1,050 | $287.96 | $300,000 |
| Kaye Mark | Apr 24, 2025 | Sell | 4,588 | $424.82 | $1.9M |
| Penczek Ronald W | Mar 10, 2025 | Sell | 443 | $415.13 | $180,000 |
| Kendrick Charles Morgan JR | Mar 5, 2025 | Sell | 3,504 | $396.3 | $1.4M |
| Kendrick Charles Morgan JR | Oct 18, 2024 | Sell | 7,417 | $432.14 | $3.2M |
| PERU RAMIRO G | Aug 5, 2024 | Sell | 753 | $531.52 | $400,000 |
| BOUDREAUX GAIL | Jul 22, 2024 | Sell | 20,779 | $500.36 | $10M |
| BOUDREAUX GAIL | Jul 22, 2024 | Sell | 6,621 | $501.4 | $3.3M |
| BOUDREAUX GAIL | Jul 22, 2024 | Sell | 2,250 | $504.27 | $1.1M |
| BOUDREAUX GAIL | Jul 22, 2024 | Sell | 1,100 | $498.5 | $550,000 |
| BOUDREAUX GAIL | Jul 22, 2024 | Sell | 1,000 | $503.67 | $500,000 |
| Dixon Robert L JR | Jul 19, 2024 | Sell | 305 | $506.76 | $150,000 |
| Norwood Felicia F | Apr 24, 2024 | Sell | 3,434 | $532.68 | $1.8M |
| Norwood Felicia F | Apr 24, 2024 | Sell | 2,765 | $532.14 | $1.5M |
| Norwood Felicia F | Apr 23, 2024 | Sell | 14,011 | $533.73 | $7.5M |
| Norwood Felicia F | Apr 23, 2024 | Sell | 100 | $534.74 | $53,000 |
| Kendrick Charles Morgan JR | Mar 8, 2024 | Sell | 2,432 | $500.46 | $1.2M |
| Penczek Ronald W | Mar 6, 2024 | Sell | 916 | $504.58 | $460,000 |
| Haytaian Peter D | Mar 4, 2024 | Sell | 15,000 | $500.18 | $7.5M |
| Haytaian Peter D | Mar 4, 2024 | Sell | 4,206 | $500.18 | $2.1M |
| Haytaian Peter D | Mar 4, 2024 | Sell | 1,889 | $500.18 | $940,000 |
| PERU RAMIRO G | Feb 7, 2024 | Sell | 753 | $500 | $380,000 |
FAQ - Insider Transactions
The most recent insider transaction for Elevance Health was conducted by DeVore Susan D., who sold 1,200 shares on August 19, 2025 at a price of $312.15 per share.
BOUDREAUX GAIL has bought the most ELV stock in the last 2 years, with a total value of $2.4M.
BOUDREAUX GAIL has sold the most ELV stock in the last 2 years, with a total value of $16M.
The total value of insider transactions for Elevance Health in the last 2 years is negative, amounting to -$44M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Elevance Health have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
